Orexigen Therapeutics, Inc. (OREX) Misses Q1 EPS by 4c
Tweet
Share
E-mailGet Alerts OREX Hot Sheet
Price: $0.22 --0%
Financial Fact:
Research and development: 5.25M
Today's EPS Names:
OFLX, NMRD, VAXX, More
Financial Fact:
Research and development: 5.25M
Today's EPS Names:
OFLX, NMRD, VAXX, More
Join SI Premium – FREE
Orexigen Therapeutics, Inc. (NASDAQ: OREX) reported Q1 EPS of ($0.16), $0.04 worse than the analyst estimate of ($0.12). Revenue for the quarter came in at $857 thousand versus the consensus estimate of $900 thousand.
For earnings history and earnings-related data on Orexigen Therapeutics, Inc. (OREX) click here.
For earnings history and earnings-related data on Orexigen Therapeutics, Inc. (OREX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance
- Actelis Networks (ASNS) Tops Q2 EPS by 63c
- Laird Superfood, Inc. (LSF) Misses Q2 EPS by 22c ; Offers Guidance
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
